MINAPHARM Pharmaceuticals

MIPH

EGS380G1C011

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
200.3 ^EGP	0.00%		0.00%	-8.00%

Apr. 07	MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Minapharm Pharmaceuticals S.A.E. Announces Consolidated Earnings Results for the Quarter Ended March 31, 2019

June 01, 2019

MINAPHARM Pharmaceuticals S.A.E. announced consolidated earnings results for the quarter ended March 31, 2019. For the quarter, net profit of EGP 43,990,085 against EGP 82,602,696 a year ago.

Latest news about MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 07	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-29	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-28	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Bioventure, Minapharm Pharmaceuticals and Migentra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa	22-11-30	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2022	22-06-01	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
MINAPHARM Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-29	CI
MINAPHARM Pharmaceuticals Reports Consolidated Earnings Results for the Six Months Ended June 30, 2021	21-08-30	CI
MINAPHARM Pharmaceuticals Reports Standalone Earnings Results for the Six Months Ended June 30, 2021	21-08-11	CI
MINAPHARM Pharmaceuticals Announces Consolidated Earnings Results for the Quarter Ended March 31, 2021	21-06-15	CI
ProBioGen AG and MINAPHARM Pharmaceuticals Incorporate MiGenTra GmbH - A Healthcare Transforming Medicines Company	21-05-27	CI
RDIF and Minapharm Agree to Produce over 40 Million Doses of the Sputnik V Vaccine in Egypt	21-04-22	CI
MINAPHARM Pharmaceuticals Announces Audited Consolidated Earnings Results for the Year Ended Dec. 31, 2020	21-03-31	CI
Shaheer Wafik Saad El Bardisy acquired an additional 10% stake in MINAPHARM Pharmaceuticals for approximately EGP 100 million.	20-07-25	CI
Minapharm Pharmaceuticals Reports Consolidated and Standalone Earnings Results for the First Quarter Ended March 2020	20-06-28	CI
Minapharm Pharmaceuticals Announces Consolidated and Standalone Earnings Results for the First Nine Months of 2019	19-11-28	CI
MINAPHARM Pharmaceuticals S.A.E. Reports Standalone Earnings Results for the Six Months Ended June 30, 2019	19-08-21	CI
Minapharm Pharmaceuticals S.A.E. Announces Consolidated Earnings Results for the Quarter Ended March 31, 2019	19-06-01	CI
MINAPHARM Pharmaceuticals S.A.E. Announces Standalone Earnings Results for the Quarter Ended March 31, 2019	19-05-14	CI
Minapharm Pharmaceuticals Declares Cash Dividend, Payable on May 29, 2019	19-05-05	CI
Minapharm Pharmaceuticals Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2018	19-04-02	CI
Minapharm Pharmaceuticals Announces Audited Standalone Earnings Results for the Year Ended December 31, 2018	19-03-30	CI

Chart MINAPHARM Pharmaceuticals

Duration

Period

More charts

Minapharm Pharmaceuticals S.A.E. specializes in developing, manufacturing and marketing prescription pharmaceutical products. The products are for the treatment of gastroenterological, ophthalmologic, cardiovascular, genetic, dermatological, orthopedic diseases, etc.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
MINAPHARM PHARMACEUTICALS	-8.00%	47.29M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+19.22%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	5.52B

Generic Pharmaceuticals

MINAPHARM Pharmaceuticals

Equities

MIPH

EGS380G1C011

Pharmaceuticals

Minapharm Pharmaceuticals S.A.E. Announces Consolidated Earnings Results for the Quarter Ended March 31, 2019

Latest news about MINAPHARM Pharmaceuticals

Chart MINAPHARM Pharmaceuticals

Company Profile

Income Statement Evolution

Sector Generic Pharmaceuticals